Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Danuta Kielar
Observed names:
D Kielar,
D. Kielar
Institution:
AstraZeneca (United Kingdom)
Observed institution:
AstraZeneca (United Kingdom)
OpenAlex ID:
A5080267206
Reduced organ damage accumulation in adult patients with SLE on anifrolumab plus standard of care compared to real-world external controls
2025
·
Zahi Touma
, Ian N. Bruce
, et al.
·
Annals of the Rheumatic Diseases
·
21
PDF
Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS)
2025
·
Martin Aringer
, Laurent Arnaud
, et al.
·
Lupus Science & Medicine
·
12
PDF
Clinical symptoms, comorbidities, treatment patterns and time to diagnosis in patients with eosinophilic oesophagitis in England: a retrospective cohort study
2024
·
Xiao Xu
, Stephanie Y Chen
, et al.
·
Frontline Gastroenterology
·
2
Healthcare resource utilization and costs in patients with eosinophilic granulomatosis with polyangiitis versus severe uncontrolled asthma: a retrospective analysis of US health insurance claims data
2024
·
Paul Dolin
, Danuta Kielar
, et al.
·
Journal of Allergy and Clinical Immunology
·
2
Impact of patient support programmes among patients with severe asthma treated with biological therapies: a systematic literature review and indirect treatment comparison
2024
·
Adrian P J Rabe
, Wei J Loke
, et al.
·
BMJ Open Respiratory Research
·
1
PDF
Clinical Characteristics of Patients with Eosinophilic Esophagitis in the UK: A Retrospective Analysis of the Clinical Practice Research Datalink (CPRD) Database
2023
·
Xiao Xu
, E. Maslova
, et al.
·
Journal of Allergy and Clinical Immunology
·
1
PDF
EGPA disease burden in Europe and US: evidence from real-world clinical practice
2025
·
Bo Ding
, Robert Spiera
, et al.
·
European Respiratory Journal
Doris Remission in Patients With Sle Treated With Anifrolumab: Post Hoc Analysis From Tulip-1 and Tulip-2 Trials in Patients With No Prior Immunosuppressant Use
2025
·
Andrea Doria
, Ronald Van Vollenhoven
, et al.
·
The Journal of Rheumatology
Real-world Treatment Patterns in Patients With Eosinophilic Granulomatosis With Polyangiitis (EGPA)
2025
·
S. Chen
, R. Spiera
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Disease States in Patients With Eosinophilic Granulomatosis With Polyangiitis (EGPA) in England: A Retrospective Observational Cohort Study
2025
·
S.H. Siddiqui
, P. Dolin
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Healthcare Resource Utilization and Associated Costs Across Three Health States in Patients With Eosinophilic Granulomatosis With Polyangiitis (EGPA): A Retrospective Observational Cohort Study in England
2025
·
S.H. Siddiqui
, P. Dolin
, et al.
·
American Journal of Respiratory and Critical Care Medicine
M13 Disease burden in patients with eosinophilic granulomatosis with polyangiitis (EGPA) in England: a retrospective cohort study
2024
·
S Siddiqui
, P Dolin
, et al.
·
Thorax
Pulmonary Involvement and Persistent Pulmonary Damage in Eosinophilic Granulomatosis With Polyangiitis (EGPA): A Retrospective Analysis of US Health Insurance Claims Data
2024
·
A. Shavit
, P. Dolin
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Comorbidities in patients with eosinophilic granulomatosis with polyangiitis and severe uncontrolled asthma: a retrospective analysis of US health insurance claims data
2024
·
Paul Dolin
, Danuta Kielar
, et al.
·
Journal of Allergy and Clinical Immunology
Demographics and Clinical Characteristics of Patients With Eosinophilic Esophagitis: a Us-based Insurance Claims Data Analysis
2022
·
X. Xu
, M. Chehade
, et al.
·
Annals of Allergy Asthma & Immunology
P148 Impact of patient support programs on outcomes among patients with severe asthma treated with biologic therapies – a systematic literature review
2022
·
APJ Rabe
, WJ Loke
, et al.
·
Thorax
S505 Characteristics of and Healthcare Cost Drivers Among U.S. Patients With Eosinophilic Esophagitis With High versus Non-High All-Cause Costs: An Analysis of Insurance Claims Data
2022
·
Xiao Xu
, Justin Kwiatek
, et al.
·
The American Journal of Gastroenterology
Show more works
View as search
Works count:
17
Citation count:
39
H-index:
2
I10-index:
2
Year
Topic
Type